Founded in 2020, SOMAREALITY develops real-time cognitive insights derived from eye-tracking data, offering biomarkers such as Cognitive Load and measures of perception, attention and fatigue. Its solution is hardware-agnostic, uses a white-box approach for personalized insights after only seconds of data, and is available both as local integrations and a web-based service, with on-chip deployment planned for wearable glasses. The company has commercial traction in B2B, reporting over €2 million in revenue since launching its first biomarker in 2024 and more than doubling revenue in 2025 through partnerships with global eye-tracking hardware and software distributors. Key markets include high-risk industries such as aviation, healthcare, professional sports and research. SOMAREALITY is pursuing longitudinal studies to track cognitive health and plans to expand into B2C as part of its growth strategy.

Total raised

$6M

Funding rounds

2

Latest round

Series A

Latest activity

Jun 2026